Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0080
-0.0002 (-2.44%)
At close: Mar 9, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Prescription Medications
1.96M2.29M2.73M4.61M6.36M
Prescription Medications Growth
-14.22%-16.39%-40.62%-27.57%-42.78%
Medical Devices
3.15M3.54M3.26M3.21M3.20M
Medical Devices Growth
-10.90%8.55%1.60%0.13%-28.31%
Total
5.11M5.82M5.99M7.81M9.56M
Total Growth
-12.20%-2.83%-23.29%-18.29%-38.63%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States
4.04M4.53M4.80M6.57M8.56M
United States Growth
-10.69%-5.68%-26.99%-23.18%-39.90%
International
1.07M1.30M1.19M1.24M1.00M
International Growth
-17.49%8.62%-3.67%23.39%-25.12%
Total
5.11M5.82M5.99M7.81M9.56M
Total Growth
-12.20%-2.83%-23.29%-18.29%-38.63%
Source: S&P Global Market Intelligence.